The World Health Organization has paused the clinical trials of anti-malarial drug hydroxychloroquine in coronavirus patients. It says the drug, notably taken and endorsed by US President Donald Trump, has raised safety concerns. The drug’s safety data is being reviewed by a monitoring board, and the trials have been put on hold, the WHO chief Tedros Adhanom Ghebreyesus told reporters. It was being tested as part of the Solidarity international program aimed at tackling the Covid-19 pandemic. The UN heath body took the step out of “abundance of caution,” said Mike Ryan, the head of the organization’s emergencies program.
Hence then, the article about who suspends trials of trump chosen hydroxychloroquine drug over safety risks for covid 19 patients was published today ( ) and is available onRussia Today ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( WHO SUSPENDS trials of Trump-chosen hydroxychloroquine drug over SAFETY RISKS for Covid-19 patients )